FC
Fore Capital Portfolio holdings
AUM
$50.2M
This Quarter Return
+0.7%
1 Year Return
+3.95%
3 Year Return
+4.38%
5 Year Return
+6.69%
10 Year Return
–
AUM
$84M
AUM Growth
+$84M
(+13%)
Cap. Flow
+$6.46M
Cap. Flow
% of AUM
7.69%
Top 10 Holdings %
Top 10 Hldgs %
62.68%
Holding
68
New
14
Increased
3
Reduced
4
Closed
8
Top Buys
| 1 |
VanEck Gold Miners ETF
GDX
|
$3.4M |
| 2 |
Fiserv
FI
|
$2.67M |
| 3 |
Enterprise Products Partners
EPD
|
$1.93M |
| 4 |
Fox Class A
FOXA
|
$1.49M |
| 5 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
$1.45M |
Top Sells
| 1 |
RSX
VanEck Russia ETF
RSX
|
$5.16M |
| 2 |
Altice USA
ATUS
|
$2.05M |
| 3 |
Newmont
NEM
|
$1.21M |
| 4 |
Pan American Silver
PAAS
|
$1.05M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$838K |
Sector Composition
| 1 | Energy | 6.75% |
| 2 | Healthcare | 6.24% |
| 3 | Communication Services | 3.86% |
| 4 | Technology | 3.68% |
| 5 | Consumer Discretionary | 2.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
XDIV
1
DELISTED
U.S. Equity Ex-Dividends Fund - Series 2027
XDIV
| $19.3M | 5.86% | 200,000 | – | – |
|
|
2
Enterprise Products Partners
EPD
$69.6B
| $4.34M | 1.32% | 180,000 +80,000 | +80% | +$1.93M |
|
|
3
VanEck Gold Miners ETF
GDX
$19B
| $3.4M | 1.04% | +100,000 | New | +$3.4M |
|
|
4
Fiserv
FI
$75.1B
| $2.67M | 0.81% | +25,000 | New | +$2.67M |
|
5
Alibaba
BABA
$322B
| $2.04M | 0.62% | 9,000 -3,000 | -25% | -$680K |
|
|
IDIV
6
DELISTED
U.S. Equity Cumulative Dividends Fund - Series 2027
IDIV
| $1.98M | 0.6% | 200,000 | – | – |
|
|
7
Fox Class A
FOXA
$26.6B
| $1.49M | 0.45% | +40,000 | New | +$1.49M |
|
|
DISCK
8
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $1.45M | 0.44% | +50,000 | New | +$1.45M |
|
9
Pfizer
PFE
$141B
| $1.37M | 0.42% | +35,000 | New | +$1.37M |
|
10
Williams Companies
WMB
$70.7B
| $1.33M | 0.4% | +50,000 | New | +$1.33M |
|
|
11
Regeneron Pharmaceuticals
REGN
$61.5B
| $1.12M | 0.34% | 2,000 -1,500 | -43% | -$838K |
|
|
12
Altice USA
ATUS
$1.1B
| $1.02M | 0.31% | 30,000 -60,000 | -67% | -$2.05M |
|
13
Bristol-Myers Squibb
BMY
$96B
| $1M | 0.31% | +15,000 | New | +$1M |
|
14
Vistra
VST
$64.1B
| $954K | 0.29% | +51,409 | New | +$954K |
|
|
SA
15
Seabridge Gold
SA
$1.78B
| $738K | 0.22% | +42,053 | New | +$738K |
|
|
TMQ
16
Trilogy Metals
TMQ
$278M
| $692K | 0.21% | 275,766 +122,020 | +79% | +$306K |
|
17
Gilead Sciences
GILD
$140B
| $689K | 0.21% | +10,000 | New | +$689K |
|
18
SPDR S&P Biotech ETF
XBI
$5.07B
| $677K | 0.21% | +5,000 | New | +$677K |
|
19
Biomerica
BMRA
$7.97M
| $541K | 0.16% | 135,000 +57,857 | +75% | +$232K |
|
|
AUD
20
DELISTED
Audacy, Inc.
AUD
| $453K | 0.14% | +105,000 | New | +$453K |
|
21
Vertex Pharmaceuticals
VRTX
$100B
| $444K | 0.14% | +2,200 | New | +$444K |
|
|
API
22
Agora
API
$313M
| $420K | 0.13% | 10,000 | – | – |
|
23
AutoZone
AZO
$70.2B
| $298K | 0.09% | 200 | – | – |
|
24
Clear Channel Outdoor Holdings
CCO
$616M
| $281K | 0.09% | 106,524 -185,000 | -63% | -$488K |
|
25
Precigen
PGEN
$1.34B
| $65K | 0.02% | +10,000 | New | +$65K |
|